Curi RMB Capital’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-89,403
Closed -$3.82M 501
2020
Q4
$3.82M Buy
89,403
+10,400
+13% +$374K 0.14% 150
2020
Q3
$2.08M Sell
79,003
-3,414
-4% -$95.1K 0.09% 189
2020
Q2
$2.21M Sell
82,417
-28,058
-25% -$633K 0.1% 194
2020
Q1
$1.99M Buy
+110,475
New +$2.1M 0.09% 198

Other funds holding HALO

Curi RMB Capital's HALO Position: Q1 2021 in Review

Curi RMB Capital sold out of Halozyme (HALO) in Q1 2021, closing a stake of 89,403 shares — an estimated $3.82M sold.

Curi RMB Capital first reported a position in HALO in Q1 2020 and held it in 4 quarters. The position peaked at $3.82M in Q4 2020. 336 funds tracked by Wall St. Rank hold HALO as of Q1 2021.

  • Curi RMB Capital reported no remaining Halozyme position as of Q1 2021 after selling out during the quarter.
  • Curi RMB Capital sold 89,403 Halozyme shares in Q1 2021, an estimated $3.82M.
  • Curi RMB Capital first reported a position in Halozyme in Q1 2020 and held it in 4 quarters.
  • Curi RMB Capital's Halozyme position peaked at $3.82M in Q4 2020.
  • 336 funds tracked by Wall St. Rank held Halozyme as of Q1 2021.

Based on Curi RMB Capital's 13F filing for Q1 2021, filed 12 May 2021.